Skip Navigation

European Heart Journal 2004 25(2):99-100; doi:10.1016/j.ehj.2003.11.001
Copyright © 2004 by the European Society of Cardiology.
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cohen, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

Progress with diabetic patients undergoing percutaneous coronary intervention

Marc Cohen*

Newark Beth Israel Medical Center, Newark USA

* Correspondence to: Dr. Marc Cohen, Chief Division of Cardiology, Cardiac Cath Lab Administration, Newark Beth Israel Medical Center, 201 Lyons Avenue, Newark, New Jersey 07112, USA. Tel: +1 973-926-7852, Fax: +1 973-282-0839
E-mail address: marcohen@sbhcs.com

Received 28 October 2003; accepted 5 November 2003

The first 10% of the full text of this article appears below.

See doi:10.1016/j.ehj.2003.11.002 for the article to which this editorial refers

A revolution has taken place. We are witnessing a time when medical intervention is quantitatively improving the clinical outcomes of diabetic patients. As physicians we knew that diabetic patients had a worse natural history than non-diabetics. As interventional cardiologists, we knew that diabetic patients suffer from much higher restenosis . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients: Insights from the RAVEL Trial
Alexandre Abizaid, Marco A. Costa, Didier Blanchard, Mariano Albertal, Hélèn Eltchaninoff, Giulio Guagliumi, Laarman Geert-Jan, Andrea S. Abizaid, Amanda G.M.R. Sousa, Egon Wuelfert, Lindeboom Wietze, J.Eduardo Sousa, Patrick W. Serruys, Marie-Claude Morice, and on behalf of the Ravel Investigators
EHJ 2004 25: 107-112. [Abstract] [FREE Full Text]